Skip to content

Useful Diet in patients with rheumatoid arthritis

Assessment of the effects of Mediterranean and low fat diets compared with regular diet on improvement of symptoms in patients with rheumatoid arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200929048876N2
Enrollment
168
Registered
2020-10-09
Start date
2020-02-19
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthiritis. Rheumatoid arthritis, unspecified

Interventions

Intervention 1: Intervention group: Mediterranean diet which contains 35% of calorie from fats, 15% from protein and 50% from carbohydrates. This diet contains 27-37 gr fiber per day. After calorie c

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 75 Years

Inclusion criteria

Inclusion criteria: Rheumatoid patients according to the US rheumatologic association criteria rheumatoid patients at the activated phase of disease body mass index between 25-35 age of 15-75 yrs Iranian ethnicity

Exclusion criteria

Exclusion criteria: pregnant or lactating women or who decided to pregnant intake of multivitamins or minerals supplements at least at the last 3 month people who are on certain diets or have been on a diet for at the last 3 month people who don't follow the prescribed diets recent weight loss more than 4 kg during the last 2 month allergy and sensitivity to fish or impossibility of consuming it opioid consumption or non-steroid anti-inflammatory drugs on a daily and continuous basis patients at the remission phase of disease other chronic diseases except of rheumatoid arthritis intake of alcohol and cigarette maldigesting diseases such as celiac and steatorrhea

Design outcomes

Primary

MeasureTime frame
Weight changes. Timepoint: baseline and after 3month. Method of measurement: scale.;Pain severity. Timepoint: baseline and after 3 month. Method of measurement: VAS and DAS28 questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mojtaba Tabatabaiee Befroodi

Zanjan University of Medical Sciences

mojtabaaatabatabaeee@yahoo.com+98 24 3315 6300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 13, 2026